Blog

November 2025 Calendar On Blue Background

There has been a dynamic mix of significant funding, major EU policy initiatives, and next-generation technology integration in European HealthTech this week. The sector is clearly shifting towards scaling proven digital models and leveraging deep tech like AI and Extended Reality (XR).🚀 Major European HealthTech Developments1. Significant Funding and Investor FocusLargest-Ever Spanish Eldercare Round: The Spanish HealthTech startup Qida secured a massive €37 million in fresh funding. This marks the largest investment round ever in the elder-care sector in Spain, highlighting a strong and growing investor appetite for scalable, tech-enabled home and long-term care models across Europe. Deep-Tech and AI Investment: Investor commentary from major conferences emphasized a strategic shift toward funding technologies that create long-term value and economic resilience. AI is noted to be transitioning from horizontal platforms to specialized industry verticals, with healthcare being a key target sector where unique data creates a competitive advantage. Funding Strength: While global digital health funding has faced headwinds, Europe has been a notable exception, recently capturing a record share of global funding with a strong preference for later-stage ventures that can demonstrate clinical validation and clear pathways to revenue. &nbsp; 2. EU Policy and Digital Transformation InitiativesThe European Union continues to focus heavily on foundational digital infrastructure and skills: Focus on AI Adoption (Apply AI Strategy): The European Commission is moving forward with its 'Apply AI Strategy,' which aims to accelerate the practical use of AI across key industries, including health. This is part of the broader effort to close Europe's "AI adoption gap" by transitioning AI from research into routine services. New Innovation Act Proposed: Plans are being set out for an EU Innovation Act to bolster technological sovereignty. Key components relevant to HealthTech include: Introducing EU-level definitions for startups and scale-ups to better target support. Establishing common rules for Regulatory Sandboxes to allow innovative health technologies to be tested in a real-world environment across member states with regulatory oversight. Boosting Digital Health Literacy: An upcoming European Digital Health Literacy Conference highlights the critical need to equip citizens, patients, and healthcare professionals with the necessary skills to fully benefit from digital health services, recognizing that literacy is key to successful digital transformation. &nbsp; 3. Next-Generation Technology in Practice Extended Reality (XR) in Education: The EU launched the LEAPXR project, an innovative research initiative to revolutionize healthcare education and research using Extended Reality (XR) technologies. This project, which secured a €1.3 million investment, aims to create immersive simulations for training healthcare professionals, improving learning outcomes, and strengthening the quality of patient care. Virtual Human Twins (VHT) Initiative: The European Commission is pushing forward its strategic vision for the European Virtual Human Twins (VHT) Initiative, a major step towards making personalized medicine a reality through advanced AI modeling. These developments show a maturing HealthTech ecosystem that is heavily supported by strategic European funding and policy, focusing on both the cutting-edge (AI, XR) and the foundational (regulatory reform, digital skills).&gt;&gt;&nbsp;This week in European MedTech was dominated by significant regulatory developments, especially in the UK, alongside notable AI-focused product news and market concerns about global trade issues. 1. Regulatory Updates and Calls for Reform The most prominent news revolves around regulatory frameworks in both the EU and the UK: MedTech Europe Urges Regulatory Overhaul: The trade group, backed by numerous national associations, has renewed its call for the European Commission to significantly improve the global competitiveness of the regulatory pathway for medical technologies (MDR/IVDR). Key requests include: Short-Term Relief: Targeted postponement of re-certification requirements for already-certified devices to prevent a market bottleneck. Longer-Term Reform: Establishing a single, accountable governance structure for Notified Bodies and accelerating the development of regulatory pathways for breakthrough and orphan/paediatric devices. Mandatory Incident Reporting Form Update: The new Manufacturer Incident Report (MIR form, version 7.3.1) is set to become mandatory in November 2025 for all serious incident reporting under the EU MDR and IVDR. This is a crucial update for manufacturers' post-market surveillance (PMS) processes. UK MHRA Rare Disease Reform: The UK's MHRA has committed to a major reform of rare disease therapy regulation. This initiative aims to increase access to treatments for the vast majority of rare diseases that currently lack approved therapies, potentially leveraging real-world data, AI/ML models, and in-silico trials for evidence generation. &nbsp; 2. Innovation, Funding, and Product Launches AI in Healthcare: The European Commission is moving forward with its "Apply AI Strategy," which aims to boost AI adoption across strategic sectors, with healthcare, pharmaceuticals, and medical devices specifically covered. Product Launches &amp; Milestones: Medtronic launched its VitalFlow ECMO system in Europe, a new one-system platform for critical care patient support. Vektor Medical secured the CE mark for its AI-assisted, non-invasive arrhythmia mapping product, vMap, opening its entry into the EU market. Quantum Surgical received a CE mark for an indication expansion to treat bone tumors/metastases with its Epione® robotic system. Funding Rounds: There's continued investment in the sector, with notable funding for companies in areas like neurostimulation (e.g., ONWARD Medical's private placement) and women's health discovery (e.g., Cyclana Bio's pre-seed round for endometriosis research). &nbsp; 3. Industry Events &amp; Focus Areas Cybersecurity Focus: Cybersecurity for medical devices remains a hot topic, especially regarding compliance with both FDA and EU MDR/IVDR requirements. This is highlighted by the upcoming MedTech World Malta 2025 conference. Robotics in Healthcare: A new study on 'Robotics in Healthcare' was published, underscoring the rapid development and diverse applications of medical robotics, which will be a key discussion point at the upcoming MEDICA 2025 trade fair.To discuss how Nelson Advisors can help your HealthTech, MedTech, Health AI or Digital Health company, please email <a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title="lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener">lloyd@nelsonadvisors.co.uk</a>

This Week in European HealthTech and MedTech: 7th November 2025

Event Details &nbsp;&nbsp; Date: Tuesday, November 18, 2025 &nbsp;&nbsp; Location: Havas Kings Cross Building, London &nbsp;&nbsp; Host: WellFounded (Founders Health &amp; Concierge Performance Medicine) &nbsp;&nbsp; Access: By invitation/application only (free for invited guests/applicants) &nbsp;&nbsp; Source: <a data-mce-href="https://wellfounded.health/summit-schedule" href="https://wellfounded.health/summit-schedule" title="https://wellfounded.health/summit-schedule" target="_blank" rel="noopener">https://wellfounded.health/summit-schedule</a> &nbsp;&nbsp; Core Theme &nbsp;&nbsp; The overarching question driving the Summit is: "Can Precision Breakthroughs, Regulatory Revolution &amp; AI (Re)Humanise Healthcare?" The goal is to explore how to "Make medicine personable again." Key Areas of Focus (The Deeper Shift) &nbsp;&nbsp; The summit is dedicated to exploring the fundamental reimagining of medicine around the individual, moving beyond just diagnostics and treatment. The topics include: &nbsp;&nbsp; Direct-to-Customer Preventive Services: Exploring the business models and innovations in consumer health that are attracting significant investment and moving care away from traditional clinical settings.Concierge Practices &amp; Human-Centred Care: Discussing new models of healthcare delivery that promise deeply personalised, high-touch, human-centred care.Longevity Clinics: Examining the radically tailored pathways and scientific developments offered by longevity and healthspan clinics.AI Redefining Medicine: Analysing how Artificial Intelligence is fundamentally changing the way patients and clinicians interact with medicine.The Fifth 'P': Personable: Moving beyond Professor Leroy Hood's "4P's" (Proactive, Precise, Preventive, Personalised) to address the need to make healthcare truly Personable. Critical Debates The Summit will also delve into the complexities and challenges of this transformation, with provocations such as: &nbsp;&nbsp; Is AI an efficiency tool that buys the profession more time, or is it dissolving the essential clinician–patient bond?Are customised therapies, biotech breakthroughs, and loosely regulated trials truly testable and scalable for the wider population?The event is designed to bring a "human lens" to the future of healthcare, from hyper-targeted treatments to achieving human flourishing.

Nelson Advisors invited to join the 'Business Case for Ultra Personalisation' Debate at the Leaders in Health Summit 2025

Nelson Advisors partner Lloyd Price will be Chairing the "HealthTech Predictions 2026' session next at HealthTechX Global alongside an esteemed panel of HealthTech and MedTech experts, Molly Gilmartin, Professor Sneh Khemka CBE, Stuart Peak and Farhan Ismail&nbsp;<a data-mce-href="https://impactx2050.com/healthtechx/agenda2025" href="https://impactx2050.com/healthtechx/agenda2025" title="https://impactx2050.com/healthtechx/agenda2025" target="_blank" rel="noopener">https://impactx2050.com/healthtechx/agenda2025</a>HealthTechX 2025 The HealthTechX 2025 Summit is a one-day event taking place on November 5, 2025, at The Hurlingham Club in London. It's a key gathering for leaders in the health technology sector, including CEOs, founders, investors, and policymakers. &nbsp;&nbsp; Agenda and Key ThemesThe summit's agenda focuses on how technology is transforming healthcare with a tangible impact. Confirmed session topics include: AI-driven diagnostics: Exploring the latest advancements and applications of artificial intelligence in medical diagnosis. The healthcare workforce gap: Discussing how technology can help address the shortage of healthcare professionals. Medical robotics: Showcasing innovations in robotics and their role in improving patient care and surgical procedures. Specific confirmed sessions for the 2025 event include:Beyond the Hype - AI's Place in HealthcareThe Evolution of Telehealth in a Post-COVID WorldHospital to Home - Enabling the Continuum of CareFrom Prescription to Prevention - The Challenge of Lifestyle ChangeMental Health and PreventionHearing from the Investors

Nelson Advisors chairing the 'HealthTech Predictions 2026' session at HealthTechX 2025

The Global Health Exhibition 2025 in Riyadh was a landmark event, showcasing Saudi Arabia’s transformation into a healthcare innovation hub and featuring major investment announcements, digital health breakthroughs, and global partnerships.Major Agreements and Investments Over $33 billion in healthcare agreements were announced, positioning Saudi Arabia as a global leader in health sector investment.​ Key hospital and infrastructure projects included $8.4 billion worth of new health facilities and expansions, such as Hayat National Hospitals’ $1.86 billion initiative and Akdital Group’s $1.41 billion Saudi entry.​ Notable investments by private groups like Mouwasat, Alrajhi Medicine, and Burjeel Holdings, each pledging close to or above $1 billion for specialty hospitals and services.​ Innovation, AI, and Digital Health This year’s focus was on smart hospitals, generative AI in healthcare, and digitization—reflecting the Vision 2030 ambition to transition from treatment to prevention.​ Highlights included the world’s first Diabetic Command Center, which uses AI with continuous glucose monitoring for proactive intervention.​ Visionaries such as Prince Khaled bin Alwaleed underlined the importance of real-time AI-powered health dashboards to track metabolic markers and optimize lifestyle at population scale.​ International Collaboration and Growth The event brought together healthcare leaders, investors, clinicians, and medtech innovators worldwide, creating strategic partnerships and knowledge exchange platforms.​ African and Moroccan hospital groups secured key Saudi market entries, reflecting Saudi’s increased openness and ambition to become a Middle East healthcare gateway.​ Public Health Achievements Saudi Arabia reported increased life expectancy (now at 79.7 years), a 38% drop in chronic disease deaths, and early screening programs covering millions—all attributed to Vision 2030 reforms.​ Infrastructure advancements included initiatives for nationwide access to advanced medical devices, digital health equity, and the integration of advanced logistics such as drone-based deliveries.​ Core Themes Digital transformation and longevity science Chronic disease management and AI monitoring Cross-sector healthcare investment and innovation Public-private partnerships for value-based health outcomes The exhibition reinforced Riyadh’s position as a global health investment destination and highlighted big advances in digital and AI-powered population health

Nelson Advisors week in Riyadh at the Global Health Exhibition 2025

White Sticky Note With 2025 October Calendar And Red Push Pin On Blue Background

Major developments in European MedTech this week primarily include key regulatory updates, significant funding and investment in innovative technologies, and ongoing consolidation:&nbsp;1. Regulatory and Policy FocusMedical Device Regulation (MDR/IVDR) Reform: Experts and industry bodies like MedTech Europe are expressing hopes that upcoming reforms to the EU's Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) will bring greater consistency, predictability, and reduced administrative burdens for stakeholders. The European Commission is reportedly working intensively on proposed reforms expected by December.AI Regulation and IntegrationThe European Medicines Agency (EMA) has initiated a stakeholder survey to define AI priorities in medicines regulation, following the European Commission publishing draft guidance on reporting serious AI incidents under the AI Act.The UK's MHRA (Medicines and Healthcare products Regulatory Agency) published a pilot report for Phase 2 of its AI Airlock initiative, which aims to provide a concrete pathway for generating evidence for AI-as-a-Medical-Device technologies within the NHS.2. Product Approvals and InnovationsGuselkumab Approval for Ulcerative Colitis (UC): The European Commission approved TREMFYA (guselkumab) for subcutaneous induction through to maintenance in adults with ulcerative colitis. This marks it as the first IL-23 inhibitor with a fully subcutaneous dose regimen for UC, offering increased flexibility and self-administration options to patients.Continuous Glucose Monitoring (CGM) Standard: MedTech Europe has backed the creation of an internationally recognized standard for CGM technologies, which is being developed by the International Standardisation Organisation (ISO) and harmonized against EU medical device regulations.Clinical Device Innovation: Medtronic concluded the UK leg of its ACM2U Truck Roadshow, a mobile innovation hub showcasing new technologies like the Corsano multi-parameter wearable for continuous patient monitoring at home.3. Funding and InvestmentSignificant Investment Rounds:UK-based HealthTech company SheMed secured a €43 million funding round to advance its personalised women's healthcare platform.London-based brain monitoring startup CoMind raised a $60 million growth round for its non-invasive device to measure blood flow and pressure in the brain.Irish MedTech projects received substantial funding, including 'SensABLATE' which received €11.1 million to create shape-sensing and tissue sensing technologies for non-surgical tumour removal.Austrian HealthTech VC Calm/Storm closed its second fund at €30 million for early-stage investment.&nbsp;4. Corporate ActivityAcquisitions: French company FIM Medical acquired Germany-based Vistec, a specialist in vision screening devices, making FIM Medical the largest developer and distributor of European occupational healthcare devices by revenue, demonstrating a trend of consolidation for international expansion.&gt;&gt;&gt;This week in European HealthTech saw a wave of major funding rounds, strategic acquisitions, and innovations in AI-driven care and medical devices. Investor confidence remains strong, especially in specialised and personalised health platforms, while market consolidation continues among device makers.1. Funding and Venture Capital Austrian HealthTech VC Calm/Storm closed a €30 million fund, already supporting 25 early-stage companies.​ Human Health, a London-based precision health startup, raised €4.7 million to expand its AI-powered, patient-first platform for chronic care and multi-condition support.​ Plural invested $60 million in London’s CoMind, which is developing a novel non-invasive brain monitoring device.​ 2. Major M&amp;A and Market Moves AstraZeneca acquired Belgian startup EsoBiotec for up to $1 billion, aiming to accelerate in vivo cell therapies for cancer.​ FIM Medical in France grew to the largest occupational health device distributor in Europe by acquiring Vistec, a German vision screening company.​ 3. Regulatory and Product Developments GE HealthCare earned CE mark for its Carevance patient monitor, debuting advanced perioperative cardiac output capabilities at a major Munich conference.​ The UK’s MHRA initiated new AI projects to improve drug safety and accelerate treatment pathways, reflecting widespread AI adoption in digital health across Europe.​ 4. Sector Trends AI-driven solutions and remote monitoring continue to command the highest valuation premiums, with investors rewarding clinically validated, scalable platforms—especially those integrating directly into clinical workflows or managing chronic care.​ Chronic and long-term condition management is now a central focus, due to rising demand and wait times in European health systems. Solutions that streamline patient data and care pathways, like Human Health’s AI platform, are gaining rapid traction.​ 5. International ExpansionAsian HealthTech firms such as VUNO and Kakao Healthcare are entering Europe, making new regulatory and partnership moves for AI-powered diagnostics in cardiac and chronic disease management.​ Overall, European HealthTech in late October 2025 is marked by sustained capital inflow, breakthroughs in AI-powered patient care, strategic consolidation of device distributors, and growing interest in AI for regulatory, monitoring, and population health applications.To discuss how Nelson Advisors can help your HealthTech, MedTech, Health AI or Digital Health company, please email<a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title=" lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener"> lloyd@nelsonadvisors.co.uk</a>

This Week in European HealthTech and MedTech: 31st October 2025

Venture Capital  concept image with business icons and copyspace.

MedTech (Medical Technology) is increasingly viewed as one of Venture Capital's most promising frontiers due to a confluence of technological innovation, massive market potential, and evolving healthcare needs.Here are the key reasons driving VC investment into the sector:1. Massive and Stable Market Growth Large Market Size and Steady Growth: The global MedTech market is a half-trillion-dollar industry and is projected to continue expanding, with consistent annual growth. This scale and stability make it an attractive long-term investment.Demographic Drivers: The aging global population and the rising prevalence of chronic diseases create continuous and increasing demand for advanced diagnostic tools, monitoring devices, and new treatment options.&nbsp;2. Technological Convergence and Innovation Integration of AI and Data: The shift from traditional hardware to digital health solutions, including apps, data analytics, and Artificial Intelligence (AI), is transforming care. VC funds are particularly interested in companies that leverage AI to:Improve diagnostics and medical imaging analysis.Personalise medicine and predict patient outcomes.Streamline administrative and clinical workflows in provider operations.Next-Generation Devices and Robotics: Advancements in areas like surgical robotics, neuromodulation, and miniaturized, sophisticated medical devices are driving significant technological breakthroughs and commercial opportunities.Remote and Proactive Care: There is a major push for devices that can move care delivery closer to the patient, such as wearable devices (e.g., CGMs, smart rings) and digital therapeutics, which reduce costs and improve convenience.3. Attractive Investment Dynamics Focus on High-Value Deals: While the number of total deals may fluctuate, VC funding is increasingly consolidated into larger, later-stage rounds, reflecting investor confidence in high-quality, high-potential companies.Measurable Impact and Sustainable Moats: Startups focusing on chronic proactive care or specific, underserved clinical needs (like women's health or oncology) often build a stronger business case. Effective solutions that demonstrate measurable clinical outcomes can often secure reimbursement from private or public health insurance, creating a more sustainable and profitable business model compared to typical consumer apps.Exits and Liquidity: While the path to market is long due to regulatory hurdles, successful MedTech companies offer compelling exit opportunities through mergers and acquisitions (M&amp;A) by large strategics (like major medical device manufacturers) or high-profile Initial Public Offerings (IPOs). Key Investment Focus Areas VC and Private Equity investors are currently homing in on companies focused on:Cardiovascular Disease Surgical robotics Women's healthAdvanced Diagnostics (In-vitro diagnostics and imaging)To discuss how Nelson Advisors can help your HealthTech, MedTech, Health AI or Digital Health company, please email <a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title="lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener" data-mce-selected="inline-boundary">lloyd@nelsonadvisors.co.uk</a>

Nelson Advisors

Blog

This Week in European HealthTech and MedTech: 7th Novembe...

Nelson Advisors invited to join the 'Business Case for Ul...

Nelson Advisors chairing the 'HealthTech Predictions 2026...

Nelson Advisors week in Riyadh at the Global Health Exhib...

This Week in European HealthTech and MedTech: 31st Octobe...

Why MedTech Is Becoming Venture Capital’s Most Promising ...